<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>18(12)</volume><submitter>Wang KE</submitter><pubmed_abstract>The purpose of this study was to analyze secondary resiliency and user experience outcomes from a novel, 8-week website-based mind-body intervention (NF-Web) for adults (18+) with neurofibromatosis (NF1, NF2, and schwannomatosis), a genetic, neurocutaneous disorder characterized by nerve sheath tumors of the central and peripheral nervous system. The study design was a secondary data analysis of a single-arm, early feasibility pilot study (September 2020-May 2021) for adults with NF (N = 28). Across participants, the mean age was 46 (SD = 13.67) and included 22 females and 6 males. Participants completed baseline and posttest assessments (t-tests), as well as exit interviews (exploratory rapid data analysis). Results demonstrated that participation was associated with pre-to-post improveme</pubmed_abstract><journal>PloS one</journal><pagination>e0295546</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10735002</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Resiliency outcomes after participation in an asynchronous web-based platform for adults with neurofibromatosis: The NF-Web study.</pubmed_title><pmcid>PMC10735002</pmcid><pubmed_authors>Lester EG</pubmed_authors><pubmed_authors>Wang KE</pubmed_authors><pubmed_authors>Vranceanu AM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Resiliency outcomes after participation in an asynchronous web-based platform for adults with neurofibromatosis: The NF-Web study.</name><description>The purpose of this study was to analyze secondary resiliency and user experience outcomes from a novel, 8-week website-based mind-body intervention (NF-Web) for adults (18+) with neurofibromatosis (NF1, NF2, and schwannomatosis), a genetic, neurocutaneous disorder characterized by nerve sheath tumors of the central and peripheral nervous system. The study design was a secondary data analysis of a single-arm, early feasibility pilot study (September 2020-May 2021) for adults with NF (N = 28). Across participants, the mean age was 46 (SD = 13.67) and included 22 females and 6 males. Participants completed baseline and posttest assessments (t-tests), as well as exit interviews (exploratory rapid data analysis). Results demonstrated that participation was associated with pre-to-post improveme</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2026-04-28T03:18:07.111Z</modification><creation>2026-04-28T03:10:32.98Z</creation></dates><accession>S-EPMC10735002</accession><cross_references><pubmed>38127915</pubmed><doi>10.1371/journal.pone.0295546</doi></cross_references></HashMap>